Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Seeman

Showing results (61-70 of 325) with videos related to

Pageof 33
Sort By:
The British Journal of Psychiatry : the Journal of Mental Science|May 2, 2002
Atypical antipsychotics, cortical D(2) receptors and sensitivity to endogenous dopamineS Kapur, P Seeman
Advances in Experimental Medicine and Biology|January 1, 1988
Dopamine D1 and D2 receptor selectivities of agonists and antagonistsP Seeman, C Ulpian
Journal of Neurochemistry|June 1, 1985
Complete conversion of brain D2 dopamine receptors from the high- to the low-affinity state for dopamine agonists, using sodium ions and guanine nucleotideD Grigoriadis, P Seeman
Science (New York, N.Y.)|August 26, 1977
Alcohol tolerance in a cholinergic nerve terminal: relation to the membrane expansion-fluidization theory of ethanol actionM Curran, P Seeman
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2000
Schizophrenia: more dopamine, more D2 receptorsP Seeman, S Kapur
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 1, 1984
The dopamine/neuroleptic receptorD Grigoriadis, P Seeman
The American Journal of Psychiatry|February 1, 1980
Elevation of brain neuroleptic/dopamine receptors in schizophreniaT Lee, P Seeman
Advances in Biochemical Psychopharmacology|January 1, 1980
Abnormal neuroleptic/dopamine receptors in schizophreniaT Lee, P Seeman
Advances in Biochemical Psychopharmacology|January 1, 1980
Ergot and catecholamine potencies at catecholamine receptorsM Titeler, P Seeman
Biochemical Pharmacology|November 15, 1981
Binding of adrenergic ligands ([3H]clonidine and [3H]WB-4101) to multiple sites in human brainP Weinreich, P Seeman
Pageof 33

Showing results (61-70 of 325) with videos related to

Sort By:
Pageof 33
The British Journal of Psychiatry : the Journal of Mental Science|May 2, 2002
Atypical antipsychotics, cortical D(2) receptors and sensitivity to endogenous dopamineS Kapur, P Seeman
Advances in Experimental Medicine and Biology|January 1, 1988
Dopamine D1 and D2 receptor selectivities of agonists and antagonistsP Seeman, C Ulpian
Journal of Neurochemistry|June 1, 1985
Complete conversion of brain D2 dopamine receptors from the high- to the low-affinity state for dopamine agonists, using sodium ions and guanine nucleotideD Grigoriadis, P Seeman
Science (New York, N.Y.)|August 26, 1977
Alcohol tolerance in a cholinergic nerve terminal: relation to the membrane expansion-fluidization theory of ethanol actionM Curran, P Seeman
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2000
Schizophrenia: more dopamine, more D2 receptorsP Seeman, S Kapur
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 1, 1984
The dopamine/neuroleptic receptorD Grigoriadis, P Seeman
The American Journal of Psychiatry|February 1, 1980
Elevation of brain neuroleptic/dopamine receptors in schizophreniaT Lee, P Seeman
Advances in Biochemical Psychopharmacology|January 1, 1980
Abnormal neuroleptic/dopamine receptors in schizophreniaT Lee, P Seeman
Advances in Biochemical Psychopharmacology|January 1, 1980
Ergot and catecholamine potencies at catecholamine receptorsM Titeler, P Seeman
Biochemical Pharmacology|November 15, 1981
Binding of adrenergic ligands ([3H]clonidine and [3H]WB-4101) to multiple sites in human brainP Weinreich, P Seeman
Pageof 33